Atricure Inc. buy UBS Group AG
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€46.43
Performance (%)
13.14%
Price
24.07.26
€27.80
Summary
This prediction is currently active. The prediction currently has a performance of 13.14%. This prediction currently runs until 18.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -8.553% | -8.553% |
| iShares Core DAX® | 0,85 % | 1,37 % |
| iShares Nasdaq 100 | -0,99 % | -3,84 % |
| iShares Nikkei 225® | -1,78 % | -8,53 % |
| iShares S&P 500 | 0,06 % | 0,61 % |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

